• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Suppression of Influenza A Virus Replication in Human Lung Epithelial Cells by Non-cytotoxic Concentrations Bafilomycin A1

tetano

Editor, Senior Moderator
Am J Physiol Lung Cell Mol Physiol. 2014 Oct 31:ajplung.00011.2014. doi: 10.1152/ajplung.00011.2014. [Epub ahead of print]
Suppression of Influenza A Virus Replication in Human Lung Epithelial Cells by Non-cytotoxic Concentrations Bafilomycin A1.
Yeganeh B1, Ghavami S1, Kroeker AL2, Mahood TH3, Stelmack GL, Klonisch T2, Coombs KM2, Halayko AJ4.
Author information
Abstract

Subcellular trafficking within host cells plays a critical role in viral life cycles, including influenza A virus (IAV). Thus, targeting relevant subcellular compartments holds promise for effective intervention to control the impact of influenza infection. Bafilomycin A1 (Baf-A1), when used at relative high concentrations (≥10 nM) inhibits vacuolar ATPase (V-ATPase), reduces endosome acidification and lysosome number, thus inhibiting IAV replication, but promoting host cell cytotoxicity. We tested the hypothesis that much lower doses of Baf-A1 also have anti-IAV activity, but without toxic effects. Thus, we assessed the anti-viral activity of Baf-A1 at different concentrations (0.1 nM-100 nM) in human alveolar epithelial cells (A549) infected with IAV strain A/PR/8/34 (H1N1). Infected and mock-infected cells pre and co-treated with Baf-A1 were harvested 0-24hrs post infection, and analyzed by immunoblotting, immunofluorescence, confocal and electron microscopy. We found that Baf-A1 had disparate concentration-dependent effects on subcellular organelles and suppressed affected IAV replication. At concentrations ≥ 10 nM Baf-A1, inhibited acid lysosome formation, which resulted in greatly reduced IAV replication and release. Notably, at a very low concentration of 0.1 nM that is insufficient to reduce lysosome number, Baf-A1 retained the capacity to significantly impair IAV nuclear accumulation as well as IAV replication and release. In contrast to the effects of high concentrations of Baf-A1, very low concentrations did not exhibit cytotoxic effects or induce apoptotic cell death, based on morphological and FACS analyses. In conclusion, our results reveal that low concentration Baf-A1 is an effective inhibitor of IAV replication, without impacting host cell viability.

Copyright ? 2014, American Journal of Physiology - Lung Cellular and Molecular Physiology.
KEYWORDS:

Apoptotic cell death; Autophagy; Influenza A Virus; Low dose Bafilomycin A1; Non-cytotoxic

PMID:
25361566
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/25361566
 
Back
Top Bottom